Association between low prostate-specific antigen levels and greater disease progression in high-grade locally-advanced prostate cancer
Journal
Journal of the Formosan Medical Association
Journal Volume
120
Journal Issue
1 Pt 2
Pages
483
Date Issued
2021-01
Author(s)
Lu, Yu-Cheng
Hung, Fan-Ching
Abstract
In advanced or high-grade prostate cancer (PCa), prostate-specific antigen (PSA) is usually elevated, however, some patients may present with low initial PSA (iPSA) levels. The objective of this study was to evaluate whether different iPSA levels were associated with dissimilar clinical outcomes among men with high-grade PCa and advanced disease after robot-assisted laparoscopic radical prostatectomy (RaLRP).
Subjects
Initial prostate-specific antigen; Prostate cancer; Radical prostatectomy
SDGs
Other Subjects
prostate specific antigen; prostate specific antigen; adult; advanced cancer; aged; Article; biochemical recurrence; cancer grading; cancer growth; controlled study; follow up; Gleason score; hazard ratio; human; laparoscopic surgery; log rank test; major clinical study; male; progression free survival; prostate cancer; robot-assisted prostatectomy; surgical margin; disease exacerbation; prostate tumor; prostatectomy; tumor recurrence; Disease Progression; Humans; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms
Publisher
Elsevier B.V.
Type
journal article